MPS Art Therapy recently caught up with first-year MPS Art Therapy student Nicole Titus, who provided insight on what led her to SVA in pursuit of a career in Art Therapy. What inspired you to pursue ...

Ultragenyx Pharmaceuticals RARE announced that the FDA has issued a Complete Response Letter (CRL) for its biologics license application (BLA) for UX111. The AAV gene therapy is being developed as a ...

Through the end of June, visitors are encouraged to view and interact with the artwork on display in the MPS Art Therapy gallery space for "In My Truth, In My Power," an exhibition presenting work by ...

Researchers are closer to finding a better way to treat children with a rare metabolic disorder called MPS I. It is caused by a deficiency of the key enzyme IDUA needed to break down complex sugars in ...

(MENAFN- EIN Presswire) EINPresswire / -- The National MPS Society announced a landmark $4 million donor-directed grant to support a pioneering gene therapy program for MPS IIIB (Sanfilippo syndrome ...

In the Spring/Summer 2018 issue, Prattfolio asked leaders from the Pratt alumni community to share their wisdom from the helm—how they inspire, improve, and ignite creativity. This is part one in a ...

SEATTLE--(BUSINESS WIRE)--Immusoft, a clinical-stage cell therapy company dedicated to improving the lives of patients with rare diseases, today announced that the U.S. Food and Drug Administration ...